IDEX Corporation

IDEX Corporation (IEX) Market Cap

IDEX Corporation has a market capitalization of .

No quote data available.

CEO: Eric D. Ashleman

Sector: Industrials

Industry: Industrial - Machinery

IPO Date: 1989-06-02

Website: https://www.idexcorp.com

IDEX Corporation (IEX) - Company Information

Market Cap: -|Sector: Industrials

Company Profile

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions, and precision gear and peristaltic pump technologies. This segment serves food and beverage, pharmaceutical and biopharmaceutical, cosmetics, marine, chemical, wastewater and water treatment, life sciences, research, and defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.

Analyst Sentiment

69%
Buy

From 15 Active Polls

1Y Forecast: $244.71

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$214

Median

$250

High Bound

$257

Average

$245

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$244.71
▲ +13.63% Upside
Low Target
$214.00
-1% Risk
Median Target
$250.00
16% Mid
High Target
$257.00
19% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 IDEX CORP (IEX) — Investment Overview

🧩 Business Model Overview

IDEX CORP operates as a diversified industrial technology company across engineered components and systems used in safety-critical and process-intensive applications. The company typically participates in two connected parts of the value chain: (1) design/engineering and qualification of components into customer equipment (often under long acceptance cycles), and (2) supply of installed-base replenishment and aftermarket needs (filters, valves, pumps, metering parts, and related consumables depending on the platform).

A common business pattern across segments is “design-in” engineering: IDEX’s products are selected for specific performance requirements (accuracy, reliability, pressure/flow boundaries, chemical compatibility, safety compliance), which then creates an installed base that drives ongoing replacement and service demand. This structure reduces the likelihood of pure commodity price competition and supports a more durable order-to-customer relationship than standard industrial hardware.

💰 Revenue Streams & Monetisation Model

Revenue monetisation is driven by a blend of project/system sales and recurring aftermarket usage. While individual contracts can be transactional, many of IDEX’s product categories exhibit repeat buying dynamics due to replacement intervals, spares, and “same-platform” upgrades inside customer equipment.

Margin drivers generally include:

  • Engineering content and application specificity: engineered pumps, valves, and components priced for performance outcomes rather than commodity specs.
  • Installed-base economics: aftermarket parts tend to be less cyclical than the initial equipment spend and can sustain gross margin through mix.
  • Operational leverage: manufacturing scale in niche platforms and cost discipline that supports profitability across industrial cycles.

🧠 Competitive Advantages & Market Positioning

IDEX’s core moat is primarily high switching costs combined with process/qualification barriers. Competitors can offer alternatives, but replacing qualified components in safety-relevant systems or precision dosing applications often involves re-validation, redesign, and downtime costs. This “re-design friction” supports customer stickiness once IDEX products are embedded.

The company also benefits from intangible assets in the form of product know-how, application engineering, and compliance-related manufacturing discipline. These assets raise the practical barrier to entry for new entrants attempting to match reliability, materials compatibility, and long-term performance.

  • Switching-cost moat: design-in qualification, ongoing compatibility requirements, and spare-part continuity.
  • Reliability and safety qualification: performance verification and compliance expectations that favor established suppliers.
  • Portfolio diversification: exposure to multiple niche end markets rather than a single industrial cycle.

Competitive benchmarking (examples):

  • Graco (fluid handling and metering systems): focuses heavily on industrial fluid transfer and precision dosing. IDEX often competes more in specialized platforms with deeper niche customization and installed-base-driven replenishment patterns across multiple end markets.
  • Parker Hannifin (industrial motion and fluid power): broad portfolio and scale. IDEX’s positioning tends to emphasize application-specific engineered components and qualification dynamics that can make procurement choices less “catalog-driven.”
  • Johnson Controls (fire and building technologies): strong position in fire detection/control ecosystems. IDEX’s focus includes engineered fire-safety components and systems where performance qualification and reliability expectations create supplier continuity.

Overall, IDEX’s strategy contrasts with broader diversified industrial peers by leaning into engineered niches where performance qualification and compatibility requirements materially affect customer switching behavior.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by structural demand trends that increase the need for precision, reliability, and safety compliance:

  • Process intensification and automation: greater deployment of automated dosing, fluid handling, and control systems in industrial production increases demand for accurate metering and durable components.
  • Biopharma and life-science expansion: scaling of biologics manufacturing and laboratory workflows supports continued procurement of precision fluid systems and compatible components.
  • Safety and regulatory compliance tailwinds: fire-safety adoption and reinforcement in commercial and industrial facilities supports recurring replacement and upgrade cycles.
  • Energy-efficiency and reliability-driven upgrades: customers increasingly prioritize operational uptime and maintenance predictability, benefiting suppliers with proven reliability and service parts.

TAM expansion is less about broad “market share fights” and more about embedding IDEX deeper into customer equipment architectures where qualification cycles and long asset lifetimes create durable replacement demand.

⚠ Risk Factors to Monitor

  • Industrial end-market cyclicality: parts of the portfolio tied to capital equipment spending can face downturn pressure if customer budgets tighten.
  • Qualification and program risk: new platform wins require engineering execution; delays or specification mismatches can slow design-in adoption.
  • Competitive pricing pressure: established competitors with scale can pressure margins if customers shift procurement toward lowest-cost alternatives for certain applications.
  • Supply chain and component constraints: engineered products depend on specific materials/components; disruptions can impact lead times and service levels.
  • Regulatory and product liability exposure (fire and safety-related categories): compliance requirements and warranty/service obligations can introduce cost volatility.
  • Acquisition integration execution: portfolio growth via acquisitions can create integration risks in manufacturing processes, procurement, and customer program continuity.

📊 Valuation & Market View

The market typically values industrial specialty platforms using EV/EBITDA and earnings durability metrics rather than pure revenue growth multiples. The valuation framework tends to place weight on:

  • Margin stability and evidence of operating leverage across cycles.
  • Cash conversion and working-capital management (especially during order and inventory fluctuations).
  • Quality of revenue mix: higher installed-base/aftermarket share often commands a better multiple due to reduced cyclicality.
  • Execution on new design-in programs and retention of qualified-supplier status.

Key valuation drivers are sustained profitability through engineered differentiation, credible aftermarket contribution, and successful integration that avoids dilution of margins and service levels.

🔍 Investment Takeaway

IDEX’s long-term investment case rests on engineered product platforms that embed into customer equipment architectures, creating high switching costs through qualification requirements and installed-base continuity. The company’s competitive positioning emphasizes reliability, compliance discipline, and application-specific performance—factors that are structurally more defensible than commodity-like industrial component supply. Upside potential is tied to continued design-in wins and aftermarket durability, while the principal risks relate to industrial cycle sensitivity, execution in engineering qualification, and integration discipline.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"IEX reported Q1 2026 revenue of $886.9M and net income of $120.0M, with diluted EPS of $1.61. On a YoY basis (vs. Q1 2025), revenue rose to 886.9M from 814.3M (+8.9%) and net income improved to 120.0M from 95.5M (+25.6%). QoQ (vs. Q4 2025), revenue eased slightly to 886.9M from 899.1M (-1.4%) while net income declined to 120.0M from 128.3M (-6.5%). Profitability was mixed over the quarter-to-quarter trajectory: net margin contracted to 13.5% in Q1 2026 from 14.3% in Q4 2025 (but remains stronger than Q1 2025 at 11.7%). Operating income and EBITDA levels were lower QoQ (EBITDA $172.4M vs. $237.4M in Q4), despite an improved YoY earnings profile. Cash flow quality remains solid for an income-generating utility/business: operating cash flow was $103.7M in Q1 2026 and free cash flow was $86.0M, after dividends of $52.8M and buybacks of $76.3M. Balance sheet resilience is supported by stable total assets (~$6.9B) and strong equity (~$4.05B). Total shareholder returns look supportive given the 1-year price momentum of +25.5% (yield is small at ~0.37%), which should meaningfully enhance the overall return picture."

Revenue Growth

Positive

YoY revenue growth of +8.9% in Q1 2026 ($886.9M vs $814.3M). QoQ revenue slipped -1.4% ($886.9M vs $899.1M), suggesting steady but slightly soft near-term demand.

Profitability

Positive

Net income YoY rose +25.6%, but QoQ net income fell -6.5%. Net margin contracted QoQ to 13.5% (from 14.3%) while remaining above Q1 2025 (11.7%).

Cash Flow Quality

Good

Q1 2026 operating cash flow of $103.7M and free cash flow of $86.0M supported shareholder returns. Dividends paid ($52.8M) and buybacks ($76.3M) were meaningful but appear manageable given positive FCF.

Leverage & Balance Sheet

Positive

Total assets were stable around $6.9B, and equity was steady (~$4.05B). Net debt remains negative (net cash) at about -$585.7M, indicating strong balance-sheet resilience.

Shareholder Returns

Strong

1-year price momentum is strong (+25.5%). Dividend yield is modest (~0.37%), so buybacks plus price appreciation likely drive most of total return.

Analyst Sentiment & Valuation

Neutral

Price ($205.92) is below the consensus target (~$236.57), implying upside, but valuation still appears rich given high earnings multiple metrics in the provided ratios.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

So What?: IDEX’s Q1 2026 results and guidance show a clear divergence: HST is strengthening on backlog-driven, higher-value application demand (data center, semiconductors, space/defense), while FMT and FSDP remain more muted due to fragmented industrial end-market volatility and limited visibility. The company delivered +5% organic sales and +10% organic orders, with adjusted EBITDA margin expanding +50 bps to 26% and HST margins +100 bps YoY—both driven by productivity, volume leverage, and price/cost, partially offset by mix. The key financial narrative is capital allocation plus mix: share repurchases of $76M in Q1 with expected continuation, and EPS raised by $0.20 to $8.35–$8.55 on unchanged 2026 EBITDA margin (26.5%–27%). Management’s cautious stance is anchored in geopolitical/industrial uncertainty, life sciences pressure (China/NIH-related), and an order-to-revenue timing gap in FMT; tariffs are flagged as largely net-neutral currently.

AI IconGrowth Catalysts

  • HST backlog build with faster-growing order wins in data center, semiconductor, space & defense; HST organic orders +17% YoY and revenue +11% YoY
  • Water platform strength within FMT, including municipal stormwater software/analytics and higher-purity water for semicon applications; FMT organic orders +9% YoY
  • 8020 portfolio focus/pruning and scaling higher-value application spaces; management links improved visibility and earnings power to acquired-business integration

Business Development

  • 8020-enabled co-engineering in space & defense participation across “optics enabling secure data transmission” and Mott filtration solutions (engineered components for mission-critical systems)
  • Referenced margin-improvement focus areas within acquired businesses: Muon, Micro-LAM, and Mott (named businesses driving current HST mix/earnings power)

AI IconFinancial Highlights

  • Organic sales growth +5% YoY (above expectations); orders +10% organically YoY
  • Adjusted EBITDA margin 26% with +50 bps expansion YoY (productivity, volume leverage, positive price/cost; mix partially offset)
  • Adjusted gross margin -40 bps YoY to 44.9% (productivity/volume leverage offset by mix)
  • Adjusted EPS materially above guided range (exact consensus/guidance not quantified in transcript)
  • Free cash flow $86M in quarter, down $5M YoY due to higher working capital investment from higher growth; expects free cash flow conversion >=100% annually
  • HST adjusted EBITDA margin +100 bps YoY (positive volume leverage, positive price/cost, productivity; unfavorable mix & acquisitions partially offset)
  • FMT adjusted EBITDA margin -10 bps YoY (productivity benefits offset by mix and volume deleverage); FSDP adjusted EBITDA margin +30 bps YoY

AI IconCapital Funding

  • Share repurchases: $76M in Q1; management expects maintaining that quarterly pace throughout 2026
  • Dividends: $53M paid in the quarter
  • Ended quarter with liquidity ~$1.1B
  • Gross leverage ~2x as of end of Q1

AI IconStrategy & Ops

  • 8020 operational flywheel: segmenting markets, clarifying where they win, reallocating capital/talent, and rationalizing/pruning portfolio areas dragging margins within acquired businesses
  • HST flow-through commentary: HST flow-through ~33% in recent quarters/this quarter; guided improvement toward mid-30% but still below historical levels due to acquired-business margin gap
  • FMT/FSDP visibility note: fulfillment/rapid turnaround limits visibility to ~midway into the quarter, influencing conservative second-half assumptions

AI IconMarket Outlook

  • Full-year 2026 organic growth raised to 3% to 4% (from prior 1% to 2%)
  • Adjusted EBITDA margin guidance unchanged: 26.5% to 27% for 2026
  • Adjusted EPS guidance raised by $0.20 to $8.35 to $8.55 (mid- to high single-digit YoY growth)
  • Q2 2026 guidance: 3% to 4% organic growth; adjusted EBITDA margin 26.5% to 27%; adjusted EPS $2.07 to $2.12
  • Tariffs: IEEPA tariffs repealed; new tariffs largely consistent with repealed set, with no significant net financial impact currently expected; IEEPA refunds expected to play out over coming months

AI IconRisks & Headwinds

  • Geopolitical overhang contributing to mixed industrial demand in FMT/FSDP; diagnostic/order cadence not uniformly improving across all subcomponents
  • Life sciences end-market headwinds: China market pressure for end customers and NIH funding/academic pressures; management expects it to remain a pressure point
  • Industrial chemical end-market softness impacting parts of FMT (globally soft chemical markets referenced)
  • Short-cycle industrial exposure: customers can quick-turn without committing; fragmented businesses and project-by-project nature create volatility in order-to-sales conversion

Q&A: Analyst Interest

  • Second-half organic deceleration: Management explained HST should stay high-single-digit to double-digit driven by backlog momentum, while FMT is forecast “bit flat.” They attributed the deceleration mainly to macro uncertainty and visibility constraints rather than a demand collapse.
  • Path to higher HST incremental margins: Management stated current HST flow-through is ~low-to-mid 30% (about 33%). Incrementals remain depressed by acquired businesses with segment margins ~26–27%, plus life sciences mix/near-term flat growth; they expect improvement into next year.
  • FMT order vs revenue mismatch and conservatism: Management said one or two quarters can mislead because order activity is consumed within the quarter. They emphasized water leading 9% organic orders and expected continued performance; they implied normalization over ~4 quarters to assess conservatism.

Sentiment: MIXED

Note: This summary was synthesized by AI from the IEX Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — IDEX Corporation (IEX) Financial Profile